Edition:
United Kingdom

Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

7.30USD
17 Oct 2018
Change (% chg)

$-0.01 (-0.14%)
Prev Close
$7.31
Open
$7.30
Day's High
$7.30
Day's Low
$7.30
Volume
5,001
Avg. Vol
3,028
52-wk High
$10.41
52-wk Low
$5.08

Latest Key Developments (Source: Significant Developments)

‍Aslan Pharmaceuticals Files For Proposed IPO In U.S.​
Tuesday, 27 Mar 2018 

March 26 (Reuters) - Aslan Pharmaceuticals Ltd <6497.TWO>::‍ASLAN PHARMACEUTICALS FILES FOR PROPOSED INITIAL PUBLIC OFFERING IN U.S.​.‍ASLAN HAS APPLIED TO LIST ITS ADSS ON NASDAQ GLOBAL MARKET UNDER TRADING SYMBOL "ASLN"​.‍LEERINK PARTNERS AND PIPER JAFFRAY & CO. ARE ACTING AS JOINT BOOK-RUNNING MANAGERS FOR THIS OFFERING​.  Full Article

Aslan Pharmaceuticals Files For U.S. IPO
Monday, 26 Mar 2018 

March 26 (Reuters) - Aslan Pharmaceuticals Ltd ::ASLAN PHARMACEUTICALS LIMITED FILES FOR U.S. IPO OF UP TO $86.3 MILLION – SEC FILING.ASLAN PHARMACEUTICALS LIMITED SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NASDAQ GLOBAL MARKET UNDER THE SYMBOL "ASLN".ASLAN PHARMACEUTICALS LIMITED SAYS LEERINK PARTNERS, PIPER JAFFRAY ARE AMONG UNDERWRITERS TO IPO.ASLAN PHARMACEUTICALS LIMITED SAYS BTIG, H.C. WAINWRIGHT & CO, CLSA ARE AMONG UNDERWRITERS TO IPO.ASLAN PHARMACEUTICALS LIMITED SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE.  Full Article

Aslan Pharmaceuticals buys full global commercial rights for Varlitinib
Wednesday, 3 Jan 2018 

Jan 3 (Reuters) - Aslan Pharmaceuticals Ltd <6497.TWO>::ASLAN PHARMACEUTICALS ACQUIRES FULL GLOBAL COMMERCIAL RIGHTS FOR VARLITINIB FROM ARRAY BIOPHARMA.ARRAY BIOPHARMA INC HAS GRANTED ASLAN FULL GLOBAL RIGHTS TO DEVELOP, MANUFACTURE AND COMMERCIALISE VARLITINIB​.ASLAN WILL MAKE AN UPFRONT PAYMENT OF $12 MILLION TO ARRAY ON SIGNATURE AND FURTHER PAYMENT OF UP TO $12 MILLION WITHIN NEXT 12 MONTHS​.ASLAN WILL MAKE UPFRONT PAYMENT TOGETHER WITH UP TO US$30 MILLION OF DEVELOPMENT AND US$75 MILLION OF COMMERCIAL MILESTONES.  Full Article

Aslan Pharmaceuticals unit to issue 67 mln new shares at T$38 per share
Monday, 13 Nov 2017 

Nov 13(Reuters) - Aslan Pharmaceuticals Ltd <6497.TWO> ::Says its unit ASLAN Pharmaceuticals Pte. Ltd plans to issue 67 million new shares at T$38 per share .  Full Article

Aslan Pharmaceuticals plan private placement of up to 45 mln shares
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Aslan Pharmaceuticals Ltd <6497.TWO> ::Says it plans to issue up to 45 million new shares via private placement, with details remaining to be determined .  Full Article